Herts, United Kingdom

Jennifer Raphy


Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Bishops Stortford, GB (1998)
  • Herts, GB (1997 - 2002)

Company Filing History:


Years Active: 1997-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jennifer Raphy

Introduction

Jennifer Raphy is a notable inventor based in Herts, GB. She has made significant contributions to the field of pharmacology, particularly in the development of compounds that target specific receptors in the body. With a total of 3 patents to her name, Raphy is recognized for her innovative approach to addressing various medical conditions.

Latest Patents

One of her latest patents focuses on non-peptide NK1 receptor antagonists. These tachykinin antagonists are designed to be highly selective and functional NK3 antagonists. The compounds developed by Raphy are expected to be useful in the treatment of a wide range of conditions, including pain, depression, anxiety, panic, schizophrenia, neuralgia, addiction disorders, inflammatory diseases, gastrointestinal disorders, vascular disorders, and neuropathological disorders.

Career Highlights

Jennifer Raphy is currently associated with Warner-Lambert Company, where she continues to advance her research and development efforts. Her work has garnered attention in the pharmaceutical industry, contributing to the understanding and treatment of complex medical issues.

Collaborations

Raphy has collaborated with esteemed colleagues, including David Christopher Horwell and Martyn C Pritchard. These partnerships have enhanced her research capabilities and broadened the impact of her inventions.

Conclusion

Jennifer Raphy exemplifies the spirit of innovation in the pharmaceutical field. Her contributions through her patents and collaborations are paving the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…